PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
April 21, 2026Open Access

GLX10 Supplementary Data and Experimental Datasets for Type 2 Diabetes Study

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSherif Salah

Discussion

Loading...

Member takes

Overview

Dataset reveals GLX10's effects on blood glucose and body weight in type 2 diabetes, indicating its potential utility.

Key Points

  • The aim is to provide comprehensive supplementary data supporting the investigation of GLX10 as a therapeutic for type 2 diabetes.
  • Included oral glucose tolerance test curves and longitudinal blood glucose data
  • Body weight measurements and detailed experimental protocols were analyzed
  • Supplementary figures illustrate experimental findings
  • Data show variations in blood glucose levels across the oral glucose tolerance tests
  • Longitudinal analysis indicates trends in body weight measurements over time
  • Western blot and ELISA data support the immunometabolic effects of GLX10

Cite This Study

Sherif Salah (2026) studied this question.

synapsesocial.com/papers/69e71423cb99343efc98d7e5https://doi.org/10.5281/zenodo.19651482
View Full Paper
Ask AI
Bookmark
Share